How to Troubleshoot and Reduce High CV in Colloidal Gold Lateral Flow Strips
Colloidal gold lateral flow assays are simple, visual and cost-effective, but high CV can limit quantitative, semi-quantitative and lot-to-lot stable applications. CV is not the result of one isolated parameter. It reflects accumulated variation from gold particles, conjugates, membranes and pads, treatment buffers, drying, assembly and reading conditions.
First separate the type of CV issue
Before troubleshooting, identify whether the variation is within the same strip area, within one lot, between lots, or across operators and environments. Different CV patterns point to different causes.
If within-lot repeatability is poor, check spraying, striping, cutting, cassette assembly, drying and reading time first. If lot-to-lot reproducibility is poor, check gold synthesis, antibody lot, labeling process, material lot, treatment buffer and environmental records.
Gold particle consistency is a source variable
Gold particle size distribution, morphology, absorption peak and stability influence antibody adsorption, color intensity and migration behavior. A broad particle-size distribution may create different surface areas, antibody loading levels and release patterns within the same conjugate batch.
During development, record synthesis temperature, reducing-agent addition method, mixing, reaction time, color change, absorbance peak and storage state. During scale-up, mixing and mass-transfer conditions become especially important and should not be treated as simple volume scaling.
Labeling process controls activity and distribution
Gold-antibody interaction is influenced by pH, antibody input, salt concentration, reaction time and mixing. Insufficient antibody input may cause weak protection and weak signal; excessive input may leave free protein, create steric effects or alter release behavior.
Use antibody-input gradients, salt stability checks, post-centrifugation supernatant observation, redispersion and strip signal together to evaluate labeling conditions. Blocking also needs validation. Too little BSA, casein or other blocker may increase nonspecific retention, while too much may reduce release.
Conjugate pad treatment controls release synchrony
The conjugate pad is the interface where dried gold conjugates return to a flowing state. Fiber structure, pore distribution, uptake speed, protein adsorption, treatment-buffer distribution and re-dissolution after drying all affect synchronized release. Ahlstrom 8964, 6613, 8951, 141, 142 and GL0194 can be evaluated according to project structure.
Treatment method matters. Dip treatment is simple, but may create lateral distribution variation and edge effects. Spraying or quantitative loading can better control liquid volume per area and reduce position-to-position release differences. Whichever method is used, formulation, loading amount, drying condition and material lot should be recorded.
Treatment buffer balances anchoring and release
Conjugate pad treatment buffers often include buffer salts, sugars, proteins, surfactants and stabilizers. Sugars support drying protection and re-dissolution, surfactants support rewetting and release, and proteins help block nonspecific sites.
When CV is high, avoid changing many components at once. Use single-factor gradients around residue, T/C line intensity, negative background and running time. Slow release can cause weak signal and positional variation; overly aggressive release can create dirty background, line diffusion or a narrow reading window.
Drying, assembly and environmental records matter
Drying affects solute migration, conjugate activity and pad re-dissolution. Slow drying may increase component migration, while drying too fast or too hot may damage protein activity. In batch production, oven temperature distribution, airflow, placement, time and humidity should be controlled.
Assembly details such as overlap distance, lamination pressure, strip width, cassette pressure, absorbent driving force and reading time can amplify CV. Many projects look acceptable during R&D but become unstable in pilot runs because these details are not quantified.
Build process QC checkpoints
Set records at gold synthesis, conjugate preparation, conjugate pad treatment, striping and spraying, drying, cutting, cassette assembly and finished-product testing. Track absorbance peak, particle appearance, conjugate lot, spraying volume, striping amount, drying time, humidity, material lot and finished-strip repeatability.
Finished-product validation should include within-lot repeatability and lot-to-lot reproducibility. A few positive samples are not enough; include negative, weak-positive and medium/high-level samples at the target reading time.
JY Biotech application note
Shanghai JY Biotechnology has served the rapid diagnostic industry for 18 years and can support discussions around colloidal gold consumables and equipment, Ahlstrom diagnostic materials, conjugate pads, sample pads, absorbent pads, backing cards, striping and spraying, and technical service.
When consulting on high CV, useful information includes gold particle size and source, labeling conditions, blocking system, conjugate pad model and treatment method, NC membrane model, spraying and striping amounts, drying conditions, sample type, reading method and current CV data. Complete information turns a vague stability issue into a testable improvement plan.
FAQ
What should be checked first when CV is high?
First identify whether it is within-lot repeatability, lot-to-lot reproducibility or reading-window instability. Then troubleshoot gold particles, conjugates, conjugate pads, treatment buffer, drying, assembly and reading conditions.
Can changing the conjugate pad reduce CV?
Possibly, but comparison should be done under the same conjugate, treatment buffer, spraying amount, NC membrane, absorbent pad and drying conditions.
Is spraying always better than dipping for pad treatment?
Not universally. Spraying or quantitative loading can improve control of liquid volume per area, but equipment and process settings must be stable. Project validation decides the best route.
Is CV control only about production equipment?
No. Equipment stability matters, but gold synthesis, antibody labeling, blocking, materials, treatment buffer, drying environment and reading method also affect CV.
RELATED